Collegium Pharma (COLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 174,116 | 170,019 | 146,633 | 118,697 | 153,225 |
| Receivables | 83,320 | 72,953 | 77,946 | 9,969 | 2,129 |
| Inventories | 15,614 | 9,643 | 7,817 | 1,813 | 1,316 |
| TOTAL | $277,888 | $255,720 | $237,512 | $133,484 | $158,575 |
| Non-Current Assets | |||||
| PPE Net | 18,988 | 11,854 | 9,274 | 1,826 | 1,038 |
| Intangibles | 335,904 | 29,503 | 44,255 | 0 | 2,103 |
| Other Non-Current Assets | 11,061 | 9,225 | 204 | 258 | 301 |
| TOTAL | $365,953 | $50,582 | $53,733 | $2,084 | $3,442 |
| Total Assets | $643,841 | $306,302 | $291,245 | $135,568 | $162,017 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 47,495 | 3,833 | 1,642 | 1,479 | 2,667 |
| Accounts payable and accrued liabilities | 10,016 | 6,247 | 12,150 | 5,684 | 9,106 |
| Accrued Expenses | 181,210 | 191,029 | 175,334 | 24,325 | 8,879 |
| TOTAL | $239,451 | $201,765 | $189,126 | $31,488 | $25,596 |
| Non-Current Liabilities | |||||
| Long Term Debt | 110,019 | 7,667 | 9,858 | 0 | 1,479 |
| Deferred Revenues | N/A | N/A | N/A | N/A | 4,944 |
| Other Non-Current Liabilities | 108,340 | 9,438 | 676 | 0 | 34 |
| TOTAL | $218,359 | $17,105 | $10,534 | $N/A | $1,513 |
| Total Liabilities | $457,810 | $218,870 | $199,660 | $31,488 | $27,109 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 34,756 | 34,051 | 33,305 | 32,994 | 29,449 |
| Common Shares | 35 | 34 | 33 | 33 | 29 |
| Retained earnings | -333,147 | -359,899 | -337,177 | -298,049 | -223,184 |
| TOTAL | $186,031 | $87,432 | $91,585 | $104,080 | $134,908 |
| Total Liabilities And Equity | $643,841 | $306,302 | $291,245 | $135,568 | $162,017 |